Approaches to M&As in pharma points to each company’s philosophy
Deal or no deal
Related Posts
National campaign launches to end prostate cancer postcode lottery
Over 135,000 people have signed a petition to prioritise a national screening programme The charity […]
Liverpool and McMaster University announce £300,000 strategic research partnership
Areas include health research across life stages, from paediatrics to health ageing and resilience The […]
UK sees 70% increase in phase I advanced therapy clinical trials in 2024
Cell and Gene Therapy Catapult reveals significant growth in UK trials The UK experienced a […]